Anna-Léa Kahn

682 total citations
27 papers, 496 citations indexed

About

Anna-Léa Kahn is a scholar working on Health, Epidemiology and Infectious Diseases. According to data from OpenAlex, Anna-Léa Kahn has authored 27 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Health, 14 papers in Epidemiology and 11 papers in Infectious Diseases. Recurrent topics in Anna-Léa Kahn's work include Vaccine Coverage and Hesitancy (17 papers), Influenza Virus Research Studies (8 papers) and Viral gastroenteritis research and epidemiology (7 papers). Anna-Léa Kahn is often cited by papers focused on Vaccine Coverage and Hesitancy (17 papers), Influenza Virus Research Studies (8 papers) and Viral gastroenteritis research and epidemiology (7 papers). Anna-Léa Kahn collaborates with scholars based in Switzerland, United States and United Kingdom. Anna-Léa Kahn's co-authors include Roland W. Sutter, Debra Kristensen, Birgitte Giersing, Anthony Burton, Luís Sarmiento, Lai Heng Hung, Alina Tejeda, R. Bruce Aylward, Magilé Fonseca and Sonia Resik and has published in prestigious journals such as New England Journal of Medicine, Social Science & Medicine and The Journal of Infectious Diseases.

In The Last Decade

Anna-Léa Kahn

25 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna-Léa Kahn Switzerland 13 255 183 179 174 79 27 496
Masahiko Hachiya Japan 14 158 0.6× 210 1.1× 51 0.3× 216 1.2× 39 0.5× 51 537
Julie Garon United States 10 422 1.7× 180 1.0× 366 2.0× 109 0.6× 51 0.6× 22 601
Emmanuel Abanida Nigeria 11 280 1.1× 138 0.8× 247 1.4× 181 1.0× 53 0.7× 17 498
Raburn M. Mallory United States 15 330 1.3× 435 2.4× 45 0.3× 85 0.5× 202 2.6× 33 863
Peter Carrasco United States 13 244 1.0× 470 2.6× 106 0.6× 315 1.8× 126 1.6× 25 781
John W. Fitzsimmons United States 8 154 0.6× 135 0.7× 96 0.5× 143 0.8× 16 0.2× 10 398
Christine Casey United States 11 207 0.8× 256 1.4× 65 0.4× 81 0.5× 95 1.2× 22 666
Jingshan Zheng China 10 222 0.9× 469 2.6× 26 0.1× 213 1.2× 112 1.4× 16 607
Emily Simons United States 11 183 0.7× 489 2.7× 19 0.1× 369 2.1× 134 1.7× 17 743
Praveen Dhankhar United States 10 223 0.9× 433 2.4× 23 0.1× 68 0.4× 55 0.7× 18 859

Countries citing papers authored by Anna-Léa Kahn

Since Specialization
Citations

This map shows the geographic impact of Anna-Léa Kahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna-Léa Kahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna-Léa Kahn more than expected).

Fields of papers citing papers by Anna-Léa Kahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna-Léa Kahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna-Léa Kahn. The network helps show where Anna-Léa Kahn may publish in the future.

Co-authorship network of co-authors of Anna-Léa Kahn

This figure shows the co-authorship network connecting the top 25 collaborators of Anna-Léa Kahn. A scholar is included among the top collaborators of Anna-Léa Kahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna-Léa Kahn. Anna-Léa Kahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hasso-Agopsowicz, Mateusz, Maarten Jansen, Balcha Masresha, et al.. (2024). Exploring Important Attributes, the Potential Use Cases and Feasibility of Introduction of Measles and Rubella Microarray Patches (MR-MAPs): Insights from Nine Countries. Vaccines. 12(9). 1084–1084. 2 indexed citations
3.
6.
Mvundura, Mercy, et al.. (2021). Vaccine innovation prioritisation strategy: Findings from three country-stakeholder consultations on vaccine product innovations. Vaccine. 39(49). 7195–7207. 20 indexed citations
7.
Giersing, Birgitte, Martin I. Meltzer, Anna-Léa Kahn, et al.. (2021). The CAPACITI Decision-Support Tool for National Immunization Programs. Value in Health. 24(8). 1150–1157. 15 indexed citations
8.
Kristensen, Debra, et al.. (2021). A global collaboration to advance vaccine product innovations – The Vaccine Innovation Prioritisation Strategy. Vaccine. 39(49). 7191–7194. 14 indexed citations
9.
Kahn, Anna-Léa, Raymond Hutubessy, Patrick Lydon, et al.. (2020). How can we evaluate the potential of innovative vaccine products and technologies in resource constrained settings? A total systems effectiveness (TSE) approach to decision-making. Vaccine X. 6. 100078–100078. 10 indexed citations
10.
Giersing, Birgitte, Anna-Léa Kahn, Courtney Jarrahian, et al.. (2017). Challenges of vaccine presentation and delivery: How can we design vaccines to have optimal programmatic impact?. Vaccine. 35(49). 6793–6797. 24 indexed citations
11.
Kahn, Anna-Léa, et al.. (2017). Extending supply chains and improving immunization coverage and equity through controlled temperature chain use of vaccines. Vaccine. 35(17). 2214–2216. 19 indexed citations
14.
Landoh, Dadja Essoya, Anna-Léa Kahn, Bayaki Saka, et al.. (2017). L’utilisation de l’approche CTC: quel impact sur la couverture vaccinale lors de la campagne préventive de vaccination contre la méningite A avec le MenAfriVac au Togo en 2014 ?. Pan African Medical Journal. 27. 38–38. 4 indexed citations
15.
Onnela, Jukka‐Pekka, Bruce E. Landon, Anna-Léa Kahn, et al.. (2016). Polio vaccine hesitancy in the networks and neighborhoods of Malegaon, India. Social Science & Medicine. 153. 99–106. 43 indexed citations
16.
Landoh, Dadja Essoya, Issifou Yaya, Anna-Léa Kahn, et al.. (2016). Predictors of incomplete immunization coverage among one to five years old children in Togo. BMC Public Health. 16(1). 968–968. 51 indexed citations
17.
Resik, Sonia, Alina Tejeda, Roland W. Sutter, et al.. (2013). Priming after a Fractional Dose of Inactivated Poliovirus Vaccine. New England Journal of Medicine. 368(5). 416–424. 105 indexed citations
18.
Gunasena, Sunethra, et al.. (2012). Prevalence of prolonged and chronic poliovirus excretion among persons with primary immune deficiency disorders in Sri Lanka. Vaccine. 30(52). 7561–7565. 27 indexed citations
19.
Waggie, Zainab, Hennie Geldenhuys, Roland W. Sutter, et al.. (2011). Randomized Trial of Type 1 and Type 3 Oral Monovalent Poliovirus Vaccines in Newborns in Africa. The Journal of Infectious Diseases. 205(2). 228–236. 11 indexed citations
20.
Kahn, Anna-Léa, et al.. (1983). Rubella immunization policies for health care personnel.. PubMed. 17(5). 805–7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026